Skip to main content
. 2018 Oct 8;10:726–736. doi: 10.1016/j.dadm.2018.09.001

Table 3.

External validation: Performance of DSI to predict conversion to MCI or any type of dementia when tested in the pooled data of Barcelona and DCN cohorts, for the total cohort and for patients with extreme values

Variable % Stable SCD, n Progressive SCD, n AUC Balanced accuracy Sensitivity Specificity PPV NPV
Demographics 232 88 0.63 57.8 61.4 54.3 33.8 78.8
APOE 203 72 0.57 57.4 47.2 67.5 34.0 78.3
Neuropsychology 232 88 0.69 63.9 63.6 64.2 40.3 82.3
CSF 90 39 0.69 61.7 59.0 64.4 41.8 78.4
MRI 100 42 0.77 67.4 73.8 61.0 44.3 84.7
Demographics + APOE + Neuropsychology + CSF + MRI 232 88 0.72 65.1 68.2 62.1 40.5 83.7
DSI < 0.2 or DSI > 0.8
 Demographics + APOE + Neuropsychology + CSF + MRI 21 38 30 0.81 78.5 83.3 73.7 71.4 84.8
DSI < 0.3 or DSI > 0.7
 Demographics + APOE + Neuropsychology + CSF + MRI 45 94 50 0.79 74.2 76.0 72.3 59.4 85.0

Abbreviations: AUC: area under the receiver operating characteristic curve; PPV, positive predictive value; NPV, negative predictive value; APOE, apolipoprotein E; DSI, Disease State Index; SCD, subjective cognitive decline.

NOTE. For the extreme DSI values, n: number of patients having the DSI value in the given range; %: percentage of patients having the DSI value in the given range. Values are presented as mean.